Physician profile
Shiv Patel
NPI 1891107793
$42,615.89
in general payments reported to CMS, 2019-2025
27 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $3,492 · 2021: $8,507 · 2022: $6,414 · 2023: $826 · 2024: $951 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,105.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $24,789.81 | 2019-2025 | |
| Pylant Medical | $10,851.88 | 2020-2025 | |
| Stryker Corporation | $4,356.50 | 2020-2025 | Mako, Pangea, Variax |
| Medtronic, INC. | $933.84 | 2021-2024 | Pivox Oblique Lateral Spinal System, V-Loc 180 |
| Pacira Pharmaceuticals Incorporated | $408.01 | 2020-2025 | Zilretta, Exparel, Iovera |
| Smith+Nephew, INC. | $357.85 | 2023-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Acumed LLC | $142.75 | 2020 | |
| Anika Therapeutics, INC. | $142.59 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $135.42 | 2025 | |
| Medinc of Texas | $50.22 | 2025 | |
| Amgen INC. | $40.51 | 2023-2025 | Prolia, Evenity, Krystexxa |
| Kerecis Limited | $38.40 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Bioventus LLC | $35.48 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Globus Medical, INC. | $33.61 | 2023 | Proximal Tibia Plate |
| Ethicon US, LLC | $32.59 | 2025 | Surgiflo Hemostatic Matrix |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $30.41 | 2020-2024 | Monovisc, Orthovisc |
| Electronic Waveform Lab, INC. | $26.81 | 2024 | |
| Mimedx Group, INC. | $25.17 | 2024 | |
| Innovation Technologies INC | $24.78 | 2024 | Irrisept |
| Spineology INC. | $24.16 | 2020 | |
| Dynasplint Systems INC. | $23.11 | 2025 | Dynasplint |
| Zimmer Biomet Holdings, INC. | $21.56 | 2023 | Persona |
| Abbott Laboratories | $20.30 | 2024 | Proclaim |
| Si-Bone, INC. | $17.84 | 2021 | |
| Abbvie INC. | $17.72 | 2022 | |
| Axogen | $17.30 | 2025 | |
| Vericel Corporation | $17.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiv Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.